We’ve featured continuous glucose monitoring (CGM) devices on Medgadget before, but they had the disadvantage of being subcutaneous, and it’s unclear how long the subcutaneous reading takes to catch up to the actual blood glucose level.
A new device from InvivoSense, a company based in Norway, is inserted through a central line port and measures, in real-time, the glucose concentration in the blood. This could help us to more accurately study the effect of “tight” vs. “permissive” glucose control. The studies so far on this subject have been contradictory, and part of the reason may be that glucose is normally measured only hourly at the most.
The sensor uses a new technological approach based on the shrinking and swelling of a boronic acid incorporated hydrogel when exposed to various glucose concentrations. This device was validated in the January 2011 issue ofAnesthesiology, and it showed remarkable correlation with the gold standard methods.
Retirado de http://medgadget.comFernando Garcia
A new device from InvivoSense, a company based in Norway, is inserted through a central line port and measures, in real-time, the glucose concentration in the blood. This could help us to more accurately study the effect of “tight” vs. “permissive” glucose control. The studies so far on this subject have been contradictory, and part of the reason may be that glucose is normally measured only hourly at the most.
The sensor uses a new technological approach based on the shrinking and swelling of a boronic acid incorporated hydrogel when exposed to various glucose concentrations. This device was validated in the January 2011 issue ofAnesthesiology, and it showed remarkable correlation with the gold standard methods.
Na unidade de cuidados intensivos (UCI) o controlo da glucose sempre foi um problema para os cirurgiões e enfermeiros que acompanham o período operatório de um paciente. O nosso corpo responde a uma operação de forma extrema desde o stress psicológico ao stress físico envolvido numa operação o nosso corpo liberta hormonas e factores que induzem a produção de glucose, o que leva a alterações bruscas que não são detectados sem uma monitorização continuada. Com o sistema de medição da InvivoSense que para além de utilizar um dos maiores avanços na medicina, a utilização da fibra óptica conjugada a um hidrogel, permite então uma monitorização contínua de glucose e um controlo permanente dos estados de hiperglicémia reduzindo quase sempre o número de infecções que se podem desenvolver nestes estados hiperglicémicos em que as bactérias têm maior facilidade em proliferar.
ResponderEliminarFernando Garcia